# The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020, Paragraph 10: Amendment of the Medicines for Human Use (Clinical Trials) (Amendment) (EU Exit) Regulations 2019


In regulation 26 (insertion of Schedule 13 (transitional provisions in relation to EU Exit)), in the inserted Schedule 13—
(a) for “exit day” in each place it occurs substitute “IP completion day”;
(b) in paragraph 3—
(i) in the heading to the paragraph, after “medicinal products” insert “into Great Britain”;
(ii) in sub-paragraph (1), after “that is imported” insert “into Great Britain”.

---
Source: https://www.legislation.gov.uk/ukdsi/2020/9780348213980/schedule/1/paragraph/10 (the official version)
Page: https://openlegislation.uk/draft-human-medicines-amendment-etc-eu-exit-regulations-2020/schedule-1/paragraph-10
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.